Worldwide, 290 million people are unaware that they are living with viral hepatitis. Without finding those individuals and linking them with care, millions will continue to suffer, and lives will be lost. On World Hepatitis Day, July 28th, we call on people from across the world to take action and raise awareness to find the "missing millions." DiaSorin is proud to help support the efforts by providing an educational webinar on Hepatitis.

Laboratory Testing for Viral Hepatitis: what's new and what has changed?

DATE: July 28th, 2020 - 9 AM PDT/ 11 AM CDT/ 12 PM EDT

SPEAKER

Dr. Robert Gish, MD

Adjunct Professor of Medicine at the University of Nevada Schools of Medicine, Adjunct Professor of Pharmacy at Skaggs School of Pharmacy and Pharmaceutical Sciences at UCSD, and a Staff Physician at Loma Linda University's Liver Transplant Clinic

ABSTRACT

The demographic profile of hepatitis B and C has seen a paradigm shift over the last 10               years and as a result clinical guidelines for hepatitis testing are changing. With updated screening recommendations on the way it is necessary to understand the role of serological markers in both diagnosis of hepatitis B virus (HBV) and monitoring HBV disease status. The best way to reduce the spread of HBV infection and to optimize patient management is through the implementation of robust serological testing; with a few caveats along the way.

LEARNING OBJECTIVES

• Understand the shift in screening recommendation for hepatitis in the clinical guidelines based on the rise of hepatitis in younger demographics including HBV and HCV
• Recognize the importance of serological markers for HBV diagnosis and management
• Identify potential caveats when testing based on serological profiles and the complexity of HBC

C.E. Credits: P.A.C.E. CE ｜ Florida CE

 DiaSorin Inc | 800.328.1482 | Email | Website